Cargando…
Predictors of Polypharmacy Among Elderly Patients in China: The Role of Decision Involvement, Depression, and Taking Chinese Medicine Behavior
Introduction: The prevalence of polypharmacy is gradually increasing in geriatrics, which may contribute to adverse effects, such as potential drug–drug and drug–disease interactions. These side effects remain an important challenge in patient safety, which has a significant impact on mortality and...
Autores principales: | Chen, Chaoyi, Feng, Zhanchun, Fu, Qian, Wang, Jia, Zheng, Zehao, Chen, Hao, Feng, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685318/ https://www.ncbi.nlm.nih.gov/pubmed/34938179 http://dx.doi.org/10.3389/fphar.2021.745688 |
Ejemplares similares
-
Is shared decision-making a determinant of polypharmacy in older patients with chronic disease? A cross-sectional study in Hubei Province, China
por: Zong, Qiao, et al.
Publicado: (2023) -
Does Having a Usual Primary Care Provider Reduce Polypharmacy Behaviors of Patients With Chronic Disease? A Retrospective Study in Hubei Province, China
por: Wang, Jia, et al.
Publicado: (2022) -
Safety of Using Traditional Chinese Medicine Injections in Primary Medical Institutions: Based on the Spontaneous Reporting System 2016–2020 in Henan Province, China
por: Yan, Ziqi, et al.
Publicado: (2022) -
What Factors Hindered the Access to Essential Anticancer Medicine in Public Hospitals for the Local Population in Hubei Province, China
por: Chen, Chaoyi, et al.
Publicado: (2021) -
Prevalence of Polypharmacy and Potentially Inappropriate Medications Use in Elderly Chinese Patients: A Systematic Review and Meta-Analysis
por: Tian, Fangyuan, et al.
Publicado: (2022)